Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma

Jueliger, S.; Lyons, J.; Cannito, S.; Pata, I.; Pata, P.; Shkolnaya, M.; Lo Re, O.; Peyrou, M.; Villarroya, F.; Pazienza, V.; Rappa, F.; Cappello, F.; Azab, M.; Taverna, P.; Vinciguerra, M. (2016). Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma. Epigenetics, 00−00.10.1080/15592294.2016.1214781.
ajakirjaartikkel
Jueliger, S.; Lyons, J.; Cannito, S.; Pata, I.; Pata, P.; Shkolnaya, M.; Lo Re, O.; Peyrou, M.; Villarroya, F.; Pazienza, V.; Rappa, F.; Cappello, F.; Azab, M.; Taverna, P.; Vinciguerra, M.
  • Inglise
Epigenetics
Taylor & Francis
1559-2294
2016
0000
Ilmunud
1.1. Teadusartiklid, mis on kajastatud Web of Science andmebaasides Science Citation Index Expanded, Social Sciences Citation Index, Arts & Humanities Citation Index ja/või andmebaasis Scopus (v.a. kogumikud)
WOS

Viited terviktekstile

dx.doi.org/10.1080/15592294.2016.1214781

Seotud asutused

IVEX Lab OÜ

Lisainfo

doi: 10.1080/15592294.2016.1214781